GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » 3-Year Revenue Growth Rate

Lipigon Pharmaceuticals AB (OSTO:LPGO) 3-Year Revenue Growth Rate : -9.20% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB 3-Year Revenue Growth Rate?

Lipigon Pharmaceuticals AB's Revenue per Share for the three months ended in Dec. 2023 was kr0.00.

During the past 3 years, the average Revenue per Share Growth Rate was -9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of Lipigon Pharmaceuticals AB was 537.40% per year. The lowest was -9.20% per year. And the median was 264.10% per year.


Competitive Comparison of Lipigon Pharmaceuticals AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipigon Pharmaceuticals AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's 3-Year Revenue Growth Rate falls into.



Lipigon Pharmaceuticals AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Lipigon Pharmaceuticals AB  (OSTO:LPGO) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Lipigon Pharmaceuticals AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Traded in Other Exchanges
Address
Tvistevagen 48 C, Umea, SWE, 90736
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines